Brexit uncertainty sees UK patients cut from heart attack drug trial UK patients have been cut from an international clinical trial to test a new heart attack drug because of uncertainties about registering new medicines after Brexit.
The drug, dutogliptin, is being tested to see if it can help regenerate cardiac muscle after a heart attack and patients in Exeter, Leeds and Clydebank in Scotland were due to take part. The Independent
See also:
The drug, dutogliptin, is being tested to see if it can help regenerate cardiac muscle after a heart attack and patients in Exeter, Leeds and Clydebank in Scotland were due to take part. The Independent
See also:
No comments:
Post a Comment